Browse companies · Biosplice Therapeutics
Biosplice Therapeutics logo

Biosplice Therapeutics stock

Biotechnology · Updated hourly
Biosplice Therapeutics price history
No price history yet — the chart builds as matches occur.

The P2P Price™ is a per-security, model-derived indicative estimate, calculated daily from a time-decayed, volume-weighted blend of bids, asks, and matches.

Highest bid
$•••.••
Lowest ask
$•••.••
Last transaction
$•••.••
Live orders
0
To view live bids & asks
Sign up

Buy Biosplice Therapeutics shares

Sign up to view historical trading trends and place an offer to buy shares. Join thousands of investors on the marketplace.

Buy shares

Sell Biosplice Therapeutics shares

Use the marketplace to understand the potential price of your shares. List anonymously and benefit from flat, transparent fees.

Sell shares

Market activity

Stay informed of the latest listings and standing bids.

🔒
Sign up to view live market activity
Sign up

About Biosplice Therapeutics

Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.

Biosplice Therapeutics last round details

DateMarch 2024 (Grant)
Capital raised$778M total
Notable investorsSands Capital Ventures, Verition Fund Management, Vickers Venture Partners, Swicorp, aMoon Fund
IndustriesHealth CareBiotechnologyLife Science

Frequently asked questions

How do I invest in Biosplice Therapeutics?

Biosplice Therapeutics is a privately held company. Accredited and institutional investors seeking exposure to pre-IPO companies can invest through the marketplace — place a bid or accept a listing, subject to the company's transfer policy.

Can I buy Biosplice Therapeutics stock?

In most cases, yes. Because these are private securities, purchases are subject to accreditation and the company's right of first refusal and final approval.

Can I sell Biosplice Therapeutics shares before it goes public?

If you hold shares, you may be able to sell them by finding a buyer on the marketplace. Your ability to sell always depends on the class of shares, holding period, and the company's transfer restrictions.

What is Biosplice Therapeutics's stock price?

As a private company, Biosplice Therapeutics has no public stock price. The P2P Price shown here is a model-derived indicative estimate; sign up to see the live order book — the actual bids and asks — and to trade.

What is the valuation of Biosplice Therapeutics?

The last known valuation is $12B, from its most recent primary funding round. Private valuations are indicative and not publicly quoted.

Is Biosplice Therapeutics publicly traded?

No. Biosplice Therapeutics remains privately held and cannot be accessed on public exchanges. Accredited investors can access it on secondary marketplaces like this one before an IPO.

Nothing on this page is an offer to buy or sell, or a solicitation of an offer, any security. Pricing is indicative — generated from platform order activity, not an executable quote.

Trade private stock now.